Cochrane · systematic review · CD000022

Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation

Minozzi, S, Pifferi, S, Brazzi, L, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Acute Respiratory InfectionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
14
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 14.3%Low 8 · 57.1%Moderate 3 · 21.4%High 1 · 7.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Topical plus systemic prophylaxis versus placebo or no treatment in adults receiving mechanical ventilation for at least 48 hours

Population: adults receiving mechanical ventilation for at least 48 hours
5 questions
OutcomeEffectEvidenceStatus / GRADE
Overall mortality
Topical plus systemic prophylaxis vs placebo or no treatment
RR 0.84 [0.73, 0.96]18 studies · 5290 participantsHigh
Respiratory tract infections
Topical plus systemic prophylaxis vs placebo or no treatment
RR 0.43 [0.35, 0.53]17 studies · 2951 participantsModerate
Downgraded: publication bias
Dropouts due to adverse events
Topical plus systemic prophylaxis vs placebo or no treatment
RR 1.06 [0.3, 3.76]4 studies · 1287 participantsLow
Downgraded: imprecision
Gastrointestinal adverse events
Topical plus systemic prophylaxis vs placebo or no treatment
RR 1.08 [0.57, 2.04]6 studies · 2637 participantsLow
Downgraded: imprecision
Allergic adverse events
Topical plus systemic prophylaxis vs placebo or no treatment
RR 1.49 [0.09, 25.33]6 studies · 2981 participantsLow
Downgraded: imprecision

Topical prophylaxis versus no topical prophylaxis in adults receiving mechanical ventilation for at least 48 hours

Population: adults receiving mechanical ventilation for at least 48 hours
9 questions
OutcomeEffectEvidenceStatus / GRADE
Overall mortality
Topical prophylaxis vs no topical prophylaxis
RR 0.96 [0.87, 1.05]22 studies · 4213 participantsModerate
Downgraded: risk of bias, imprecision
Overall mortality ‐ topical plus systemic prophylaxis versus systemic prophylaxis alone
Topical prophylaxis vs no topical prophylaxis
RR 0.92 [0.72, 1.18]7 studies · 939 participantsLow
Downgraded: risk of bias, imprecision
Overall mortality ‐ topical prophylaxis versus placebo or no treatment
Topical prophylaxis vs no topical prophylaxis
RR 0.97 [0.87, 1.07]15 studies · 3274 participantsModerate
Downgraded: risk of bias, imprecision
Respiratory tract infections
Topical prophylaxis vs no topical prophylaxis
RR 0.57 [0.44, 0.74]19 studies · 2698 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, publication bias
Respiratory tract infections ‐ topical plus systemic prophylaxis versus systemic prophylaxis alone
Topical prophylaxis vs no topical prophylaxis
RR 0.82 [0.58, 1.16]6 studies · 850 participantsLow
Downgraded: risk of bias, imprecision, publication bias
Respiratory tract infections ‐ topical prophylaxis versus no treatment or placebo
Topical prophylaxis vs no topical prophylaxis
RR 0.5 [0.36, 0.69]13 studies · 1848 participantsLow
Downgraded: risk of bias, imprecision, publication bias
Dropouts due to adverse events
Topical prophylaxis vs no topical prophylaxis
RR 2.2 [0.57, 8.54]7 studies · 1323 participantsVery low
Downgraded: risk of bias, imprecision
Gastrointestinal adverse events
Topical prophylaxis vs no topical prophylaxis
RR 2.78 [0.26, 29.5]3 studies · 1859 participantsLow
Downgraded: imprecision
Allergic adverse events
Topical prophylaxis vs no topical prophylaxis
RR 2.64 [0.34, 20.69]5 studies · 2357 participantsVery low
Downgraded: risk of bias, imprecision